Learning Objectives:

1. Understand the mechanisms involved in lupus skin inflammation.

2. Understand how type I interferons can impact predisposition to skin inflammation.

3. Predict how emerging therapies may impact skin inflammation in lupus patients.

 

Session date: 
Tuesday, December 17, 2019 - 8:30am to 9:30am
Speaker Name: 
J. Michelle Kahlenberg, M.D., Ph.D.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.